Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 11.00
+0.50 (4.76%)
Jun 16, 2025, 4:35 PM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 46.56 million as of June 16, 2025. Its market cap has increased by 99.90% in one year.
Market Cap
46.56M
Enterprise Value
41.23M
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 46.56M, a decrease of -58.74%. That is a compound annual growth rate of -22.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 46.56M | 30.95% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.36B |
| GSK plc | 61.23B |
| Haleon | 35.62B |
| Smith & Nephew | 9.57B |
| ConvaTec Group | 5.88B |
| Hikma Pharmaceuticals | 4.69B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.30B |